MITA welcomes House passage of medical device user fee act

The U.S. House of Representatives passed the reauthorization of the Medical Device User Fee Act (MDUFA IV) on July 12, legislation providing new indications for imaging device manufacturers.

Without the bill being signed into law, the FDA’s authority to collect user fees from companies it regulates would expire at the end of September. The agency has warned that unless its enacted by the end of July, it would need to lay off thousands of FDA employees. The bill had enough support in the House to pass by voice vote.

The move was welcomed by the Medical Imaging & Technology Alliance (MITA), which supported the FDA’s continued authority on new indications for imaging device manufacturers and the provision requiring a report on quality and safety of devices.

“MITA is encouraged by the reauthorization of MDUFA by the House and sees the user fee agreement as a win for patients, the industry and the agency,” said Joe Robinson, chairman of the MITA board of directors and senior vice president of health systems solutions at Philips Healthcare. “We are hopeful that the momentum of this legislation in Congress will take it over the finish line in the Senate and that it will be signed into law in short order.”

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.